ONPH (Oncology Pharma) Accounts Payable: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Oncology Pharma Accounts Payable?

Oncology Pharma ONPH Accounts Payable is $0.00 Mil as of Dec. 2025.

Oncology Pharma's Accounts Payable for the quarter that ended in Dec. 2025 was $0.00 Mil.

Oncology Pharma Accounts Payable Related Terms

Oncology Pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Accounts Payable Chart

Oncology Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oncology Pharma Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oncology Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.00 Mil mean?
Oncology Pharma (ONPH) has a Accounts Payable of $0.00 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Oncology Pharma and its competitors.
Is Oncology Pharma's Accounts Payable too high?
Oncology Pharma's current Accounts Payable is $0.00 Mil.
How does Oncology Pharma's Accounts Payable compare to TAUG and IMUN?
Oncology Pharma's Accounts Payable of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Diversified Financial Services company?
A good Accounts Payable depends on the Diversified Financial Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Oncology Pharma and its competitors. Oncology Pharma's current Accounts Payable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Accounts Payable of $0.00 Mil. The current Accounts Payable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Accounts Payable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc. is a U.S.-based company that, following the divestiture of its historical drug development operations, has functioned primarily as a shell or holding entity without active business operations. Its earlier activities centered on oncology-focused pharmaceutical development, including research into targeted cancer therapies and related drug delivery technologies. The company does not currently manufacture or sell products, generate recurring revenue, or serve a defined customer base, and it has no significant geographic markets. Its public listing has been associated with over-the-counter trading, and its activities have largely consisted of seeking financing, evaluating strategic alternatives, and pursuing potential merger or acquisition opportunities to establish a new operating business. As a result, its prospects depend on completing a transaction rather than on commercial operations.